Click
here to close Hello! We notice that
you are using Internet Explorer, which is not supported by Echinobase
and may cause the site to display incorrectly. We suggest using a
current version of Chrome,
FireFox,
or Safari.
Molecules
2016 Oct 20;2110:. doi: 10.3390/molecules21101390.
Show Gene links
Show Anatomy links
Structurally Related Monoterpenes p-Cymene, Carvacrol and Thymol Isolated from Essential Oil from Leaves of Lippia sidoides Cham. (Verbenaceae) Protect Mice against Elastase-Induced Emphysema.
Games E
,
Guerreiro M
,
Santana FR
,
Pinheiro NM
,
de Oliveira EA
,
Lopes FD
,
Olivo CR
,
Tibério IF
,
Martins MA
,
Lago JH
,
Prado CM
.
???displayArticle.abstract???
BACKGROUND: Chronic obstructive pulmonary disease (COPD) is characterized by irreversible airflow obstruction and inflammation. Natural products, such as monoterpenes, displayed anti-inflammatory and anti-oxidant activities and can be used as a source of new compounds to COPD treatment. Our aim was to evaluate, in an elastase-induced pulmonary emphysema in mice, the effects of and underlying mechanisms of three related natural monoterpenes (p-cymene, carvacrol and thymol) isolated from essential oil from leaves Lippia sidoides Cham. (Verbenaceae).
METHODS: Mices received porcine pancreatic elastase (PPE) and were treated with p-cymene, carvacrol, thymol or vehicle 30 min later and again on 7th, 14th and 28th days. Lung inflammatory profile and histological sections were evaluated.
RESULTS: In the elastase-instilled animals, the tested monoterpenes reduced alveolar enlargement, macrophages and the levels of IL-1β, IL-6, IL-8 and IL-17 in bronchoalveolar lavage fluid (BALF), and collagen fibers, MMP-9 and p-65-NF-κB-positive cells in lung parenchyma (p < 0.05). All treatments attenuated levels of 8-iso-PGF2α but only thymol was able to reduced exhaled nitric oxide (p < 0.05).
CONCLUSION: Monoterpenes p-cymene, carvacrol and thymol reduced lung emphysema and inflammation in mice. No significant differences among the three monoterpenes treatments were found, suggesting that the presence of hydroxyl group in the molecular structure of thymol and carvacrol do not play a central role in the anti-inflammatory effects.
Figure 1. Structure of monoterpenes p-cymene, carvacrol and thymol.
Figure 2. Effects of monoterpenes p-cymene, carvacrol and thymol on lung inflammation. Data are presented as mean ± standard error (SE) (n = 7 to 8 mice/group) of number of cells recovered in bronchoalveolar lavage fluid collected at the 28th day of the experimental protocol. SAL + VE: control group with vehicle treatment; PPE + VE: porcine pancreatic elastase instillation and vehicle treatment; PPE + TM: porcine pancreatic elastase instillation and thymol treatment; PPE + CV: porcine pancreatic elastase instillation and carvacrol treatment; PPE + pC: porcine pancreatic elastase instillation and p-cymene treatment. * p < 0.01 and #
p < 0.05.
Figure 3. Effects of monoterpenes thymol, carvacrol and p-cymene in BALF cytokine levels. Data are presented as mean ± standard error (SE) (n = 6 to 8 mice/group) of levels of: IL-6 (A); KC (B); IL-1β (C); and IL-17 (D) detected in BALF of mice on the 28th day of the experimental protocol. SAL + VE: control group with vehicle treatment; PPE + VE: porcine pancreatic elastase instillation and vehicle treatment; PPE + TM: porcine pancreatic elastase instillation and thymol treatment; PPE + CV: porcine pancreatic elastase instillation and carvacrol treatment; PPE + pC: porcine pancreatic elastase instillation and p-cymene treatment. * p < 0.01, ** p < 0.001 and #
p < 0.05.
Figure 4. Effects of monoterpenes thymol, carvacrol and p-cymene on alveolar septa. Data are presented as mean ± standard error (SE) (n = 5 mice/group) of: mean linear intercepts (Lm) (A); volume proportion of collagen fibers (B); and the number of positive cells to MMP-9 (C); and TIMP-1 (D) in lung of mice in the 28th day of the protocol. The photomicrographs represent the lung tissue of one animal from control (E,L,Q,V), PPE treated with vehicle (F,M,R,W) and PPE treated with thymol (G,N,S,X), carvacrol (H,O,T,Y) or p-cymene group (K,P,U,Z) stained with HE (first line), picro-sirius to detect collagen fibers (second line), by immunohistochemistry to MMP-9 and TIMP-1 (third and fourth line respectively). Arrows indicate lung emphysema, collagen deposition and positive cells. SAL + VE: control group with vehicle treatment; PPE + VE: porcine pancreatic elastase instillation and vehicle treatment; PPE + TM: porcine pancreatic elastase instillation and thymol treatment; PPE + CV: porcine pancreatic elastase instillation and carvacrol treatment; PPE + pC: porcine pancreatic elastase instillation and p-cymene treatment. * p < 0.01, ** p < 0.001 and #
p < 0.05.
Figure 5. Effects of monoterpenes thymol, carvacrol and p-cymene in the NF-κB expression in alveolar septa and oxidative stress pathway. Data are presented as mean ± standard error (SE) (n = 5 to 7 mice/group) of the number of positive cells to NF-κB (A) detected in alveolar septa, the volume proportion of 8-iso-PGF-2α expression (B) detected in alveolar septa and exhaled nitric oxide detected in the exhaled air (C) from mice in the day 28 of the protocol. Panels D to H represent tissue stained to detect NF-κB and panels I to M to detect isoprostane by immunohistochemistry. Arrows represent positive cells in lung tissue. SAL + VE: control group with vehicle treatment; PPE + VE: porcine pancreatic elastase instillation and vehicle treatment; PPE + TM: porcine pancreatic elastase instillation and thymol treatment; PPE + CV: porcine pancreatic elastase instillation and carvacrol treatment; PPE + pC: porcine pancreatic elastase instillation and p-cymene treatment. * p < 0.01, ** p < 0.001 and #
p < 0.05.
Figure 6. Monoterpenes probably mechanism is related to reduction in inflammation, oxidative stress and in NF-κB in lung of PPE-instilated animals. (A) The PPE instillation induces inflammation and increase marker of oxidative stress. Cytokines such as IL-6, KC, IL-1β and IL-17 are released and induce the perpetuation of inflammation. Together with oxidative stress, there is activation in NF-κB pathway, which in turn up-regulated transcription of proinflammatory cytokines and iNOS, that can induce an increase in exhaled nitric oxide. Augment in MMP-9 positive cells can amplify inflammation and contribute to the destruction of lung tissue culminating with collagen fibers deposition; (B) The administration of monoterpenes led to a reduction of the inflammatory process and consequent reduction in oxidative stress, which is related to the effects of monoterpenes in cytokines reduction (IL-6, KC, IL-1b and IL-17), NF-κB and isoprostane. These anti-inflammatory and antioxidant effects contributed to reduction in tissue destruction.
Anciães,
Respiratory mechanics do not always mirror pulmonary histological changes in emphysema.
2011, Pubmed
Anciães,
Respiratory mechanics do not always mirror pulmonary histological changes in emphysema.
2011,
Pubmed
Antczak,
Exhaled eicosanoids and biomarkers of oxidative stress in exacerbation of chronic obstructive pulmonary disease.
2012,
Pubmed
Antunes,
Elastase-induced pulmonary emphysema: insights from experimental models.
2011,
Pubmed
Antus,
Oxidative stress in COPD: molecular background and clinical monitoring.
2015,
Pubmed
Atkinson,
Matrix metalloproteinase-9 in lung remodeling.
2003,
Pubmed
Bakkali,
Biological effects of essential oils--a review.
2008,
Pubmed
Barnes,
Chronic obstructive pulmonary disease: molecular and cellular mechanisms.
2003,
Pubmed
Barnes,
Alveolar macrophages as orchestrators of COPD.
2004,
Pubmed
Blackwell,
The role of nuclear factor-kappa B in cytokine gene regulation.
1997,
Pubmed
Boots,
Oxidant metabolism in chronic obstructive pulmonary disease.
2003,
Pubmed
Boskabady,
Lung inflammation changes and oxidative stress induced by cigarette smoke exposure in guinea pigs affected by Zataria multiflora and its constituent, carvacrol.
2015,
Pubmed
Bozic,
The murine interleukin 8 type B receptor homologue and its ligands. Expression and biological characterization.
1994,
Pubmed
Bozinovski,
Innate cellular sources of interleukin-17A regulate macrophage accumulation in cigarette- smoke-induced lung inflammation in mice.
2015,
Pubmed
Burt,
Essential oils: their antibacterial properties and potential applications in foods--a review.
2004,
Pubmed
Caramori,
Cytokine inhibition in the treatment of COPD.
2014,
Pubmed
Cataldo,
Matrix metalloproteinase-9, but not tissue inhibitor of matrix metalloproteinase-1, increases in the sputum from allergic asthmatic patients after allergen challenge.
2002,
Pubmed
Cavalcante,
The role of oxidative stress in COPD: current concepts and perspectives.
2009,
Pubmed
D'Acquisto,
From IL-15 to IL-33: the never-ending list of new players in inflammation. Is it time to forget the humble aspirin and move ahead?
2010,
Pubmed
Di Stefano,
T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients.
2009,
Pubmed
Edwards,
Targeting the NF-kappaB pathway in asthma and chronic obstructive pulmonary disease.
2009,
Pubmed
Gagliardo,
Non-invasive markers of airway inflammation and remodeling in childhood asthma.
2009,
Pubmed
Gemicioglu,
Fractional exhaled nitric oxide (FeNo) in different asthma phenotypes.
2014,
Pubmed
Grzela,
Airway Remodeling in Chronic Obstructive Pulmonary Disease and Asthma: the Role of Matrix Metalloproteinase-9.
2016,
Pubmed
Hang,
Expressions of intestinal NF-kappaB, TNF-alpha, and IL-6 following traumatic brain injury in rats.
2005,
Pubmed
Inonu,
Oxidative stress levels in exhaled breath condensate associated with COPD and smoking.
2012,
Pubmed
Jones,
Interleukin-17 stimulates the expression of interleukin-8, growth-related oncogene-alpha, and granulocyte-colony-stimulating factor by human airway epithelial cells.
2002,
Pubmed
Kacem,
Effects of essential oil extracted from Nigella sativa (L.) seeds and its main components on human neutrophil elastase activity.
2006,
Pubmed
Khan,
Medicinal Plants in Light of History: Recognized Therapeutic Modality.
2014,
Pubmed
Khan,
Carum copticum and Thymus vulgaris oils inhibit virulence in Trichophyton rubrum and Aspergillus spp.
2014,
Pubmed
Ko,
Exhaled breath condensate levels of 8-isoprostane, growth related oncogene alpha and monocyte chemoattractant protein-1 in patients with chronic obstructive pulmonary disease.
2006,
Pubmed
Krstic,
An Overview of Interleukin-17A and Interleukin-17 Receptor A Structure, Interaction and Signaling.
2015,
Pubmed
Kurimoto,
IL-17A is essential to the development of elastase-induced pulmonary inflammation and emphysema in mice.
2013,
Pubmed
Lappalainen,
Interleukin-1beta causes pulmonary inflammation, emphysema, and airway remodeling in the adult murine lung.
2005,
Pubmed
Lopes,
A comparative study of extracellular matrix remodeling in two murine models of emphysema.
2013,
Pubmed
Lorè,
The IL-17A/IL-17RA axis in pulmonary defence and immunopathology.
2016,
Pubmed
Lourenço,
A treatment with a protease inhibitor recombinant from the cattle tick (Rhipicephalus Boophilus microplus) ameliorates emphysema in mice.
2014,
Pubmed
MacNee,
Pathogenesis of chronic obstructive pulmonary disease.
2005,
Pubmed
Maione,
Interleukin 17 sustains rather than induces inflammation.
2009,
Pubmed
Maione,
Medicinal plants with anti-inflammatory activities.
2016,
Pubmed
Malerba,
Exhaled nitric oxide as a biomarker in COPD and related comorbidities.
2014,
Pubmed
Murugan,
Signal transduction pathways linking the activation of alveolar macrophages with the recruitment of neutrophils to lungs in chronic obstructive pulmonary disease.
2009,
Pubmed
Muñoz-Barrutia,
Quantification of lung damage in an elastase-induced mouse model of emphysema.
2012,
Pubmed
Ohnishi,
Tissue regeneration as next-generation therapy for COPD--potential applications.
2008,
Pubmed
Panday,
Transcription Factor NF-κB: An Update on Intervention Strategies.
2016,
Pubmed
Pappas,
The role of macrophages in obstructive airways disease: chronic obstructive pulmonary disease and asthma.
2013,
Pubmed
Pauwels,
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.
2001,
Pubmed
Perea,
CIGB-300, a synthetic peptide-based drug that targets the CK2 phosphoaceptor domain. Translational and clinical research.
2011,
Pubmed
Prado,
Effects of nitric oxide synthases in chronic allergic airway inflammation and remodeling.
2006,
Pubmed
Rahman,
IL-17R activation of human airway smooth muscle cells induces CXCL-8 production via a transcriptional-dependent mechanism.
2005,
Pubmed
Rainsford,
Anti-inflammatory drugs in the 21st century.
2007,
Pubmed
Rajendrasozhan,
Deacetylases and NF-kappaB in redox regulation of cigarette smoke-induced lung inflammation: epigenetics in pathogenesis of COPD.
2008,
Pubmed
Rauf,
Suppression of inflammatory response by chrysin, a flavone isolated from Potentilla evestita Th. Wolf. In silico predictive study on its mechanistic effect.
2015,
Pubmed
Riachi,
Peppermint antioxidants revisited.
2015,
Pubmed
Ruberto,
Antioxidant and antimicrobial activity of Foeniculum vulgare and Crithmum maritimum essential oils.
2000,
Pubmed
Rufino,
Cellular and biochemical bases of chronic obstructive pulmonary disease.
2006,
Pubmed
Schuliga,
NF-kappaB Signaling in Chronic Inflammatory Airway Disease.
2015,
Pubmed
Silva O,
[Cellular effectors of the inflammatory response in chronic obstructive pulmonary disease (COPD)].
2015,
Pubmed
Sivamani,
Comparative molecular docking analysis of essential oil constituents as elastase inhibitors.
2012,
Pubmed
Soler,
Airway inflammation and bronchial microbial patterns in patients with stable chronic obstructive pulmonary disease.
1999,
Pubmed
Stegmaier,
Dynamics of neutrophilic NF-kB translocation in relation to IL-8 mRNA expression after major trauma.
2008,
Pubmed
Sun,
Paeoniflorin attenuates allergic inflammation in asthmatic mice.
2015,
Pubmed
Taguchi,
A flavanone from Baccharis retusa (Asteraceae) prevents elastase-induced emphysema in mice by regulating NF-κB, oxidative stress and metalloproteinases.
2015,
Pubmed
,
Echinobase
Tanino,
Increased levels of interleukin-8 in BAL fluid from smokers susceptible to pulmonary emphysema.
2002,
Pubmed
Toledo,
Aerobic exercise attenuates pulmonary injury induced by exposure to cigarette smoke.
2012,
Pubmed
Toledo,
Flavonone treatment reverses airway inflammation and remodelling in an asthma murine model.
2013,
Pubmed
Tufvesson,
Inflammatory biomarkers in sputum predict COPD exacerbations.
2013,
Pubmed
Walde,
p-Cymene metabolism in rats and guinea-pigs.
1983,
Pubmed
Willis,
IL-17RA Signaling in Airway Inflammation and Bronchial Hyperreactivity in Allergic Asthma.
2015,
Pubmed
Wright,
Animal models of chronic obstructive pulmonary disease.
2008,
Pubmed
Xie,
p-Cymene protects mice against lipopolysaccharide-induced acute lung injury by inhibiting inflammatory cell activation.
2012,
Pubmed
Zhang,
Expression of interleukin (IL)-10, IL-17A and IL-22 in serum and sputum of stable chronic obstructive pulmonary disease patients.
2013,
Pubmed
Zhao,
1,8-cineol attenuates LPS-induced acute pulmonary inflammation in mice.
2014,
Pubmed
Zhou,
Thymol attenuates allergic airway inflammation in ovalbumin (OVA)-induced mouse asthma.
2014,
Pubmed
de Araújo,
Essential oils components as a new path to understand ion channel molecular pharmacology.
2011,
Pubmed